Ivan Rosas is a Respiratory physician affiliated with Baylor College of Medicine. OpenAlex indexes 429 publications with 24,562 citations (h-index 76); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7200 Cambridge St Fl 8
Houston, TX 770304202
Telephone
713-798-2400Provider last certified this registry record 31 Oct 2024.
Clinical trials
- Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)
Sponsor: Brigham and Women's Hospital
- Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
Sponsor: Brigham and Women's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20252 payments
- AtriCure, Inc.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20244 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
78.9%Kinase inhibitor78.9%Ofev100%Part D≥18 patientsAnti-infectives
12.9%Short-acting sulfonamides12.9%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsMetabolism & gastrointestinal
8.2%Corticosteroid8.2%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Respiratory Research
2023 - Characterization of the COPD alveolar niche using single-cell RNA sequencing
Nature Communications
2022 - Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
New England Journal of Medicine
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
Garabed Eknoyan, MD
Baylor College of Medicine
Sankar Navaneethan, MD
Baylor College of Medicine
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”